medline.ch Hämatologie Neoplasie

	CD19/BCMA-Targeted Chimeric Antigen Receptor-T Cell Therapy for Anti-HLA Antibody Sensitisation in Patients With Acute Leukaemia: A Pilot Clinical Study. HLA Zheng H, Zhao H, Zhu X, Feng J, Wei G, Han S, Huang S, Cui J, Fu S, Zhang M, Zhang Y, Shi J, Luo Y, Chang AH, Hu Y, Huang H. PMID: 42141373 [PubMed - indexed for MEDLINE]
	Metabolic vulnerabilities and therapeutic opportunities in diffuse large B-cell lymphoma. Oncogenesis Neumann MA, Frezza C. PMID: 42140916 [PubMed]
	Radiotherapy in Primary Central Nervous System Lymphoma: Evolution of its role and current position in combined treatment strategies. Crit Rev Oncol Hematol Zhu H, Zhou K, Yang Y, Xu B, Sun W, Su X, Luo J. PMID: 42140458 [PubMed - as supplied by publisher]
	Plasmablastic Lymphoma: 2026 Update on Diagnosis, Risk Stratification, and Management. Am J Hematol Castillo JJ, Beltrán BE, Florindez JA, Chavez JC, Malpica L. PMID: 42138287 [PubMed - as supplied by publisher]
	Long non-coding RNAs and survival outcomes in chronic lymphocytic leukemia. Pharmacogenomics Karan-Djurasevic T, Marjanovic I, Tosic N. PMID: 42138219 [PubMed - as supplied by publisher]
	Challenges in Diagnosing High-grade B-cell Lymphoma, NOS: Poor Interobserver Agreement on Its Morphologic Definition-An LLMPP Study. Am J Surg Pathol Kurz KS, Ondrejka SL, Collinge B, Slack GW, Farinha P, Rosenwald A, Campo E, Amador C, Greiner TC, Raess PW, Song JY, Jaffe ES, Weisenburger DD, Chan WC, Beiske K, Fu K, Delabie J, Pittaluga S, Feldman AL, Rimsza LM, Scott DW, Ott G, Cook JR. PMID: 42138053 [PubMed - as supplied by publisher]
	Primary thyroid lymphoma with Hashimoto's thyroiditis: A case report and literature review. Oncol Lett Liu F, Xin X, Tan K, Chen X, Shen C, Yang Q. PMID: 42137462 [PubMed]
	Diagnostic and therapeutic challenges of locally advanced colon cancer complicated with acute lymphoblastic leukemia: A case report. Oncol Lett Zeng Y, Mu S, Li G, Liang Z, Ji Q, Zhen Y, Wang W, Chen W. PMID: 42137457 [PubMed]
	Sedation with Oral Dexmedetomidine Premedication in Pediatric Patients With Acute Lymphoblastic Leukemia Undergoing Blood Sampling: A Randomized, Double-Blind Clinical Trial. Pediatr Blood Cancer Khoddami F, Naderisorki M, Ghazaeian M, Karami H, Salehifar E, Hosseinnataj A. PMID: 42136065 [PubMed - as supplied by publisher]
	Serological Benefit of SARS-CoV-2 Vaccination Relative to Infection in Children With Acute Lymphoblastic Leukemia. Pediatr Blood Cancer Shapiro JR, Qi F, Colwill K, Dorogy AD, Liu Y, Science M, Gingras AC, Rini JM, Gupta S, Alexander S, Bolotin S, Watts TH. PMID: 42135995 [PubMed - as supplied by publisher]
	A multi-center study on the consistency of drug sensitivity testing in patients with acute myeloid leukemia. NPJ Precis Oncol Willoch-Allen K, Zhao Z, Ayuda-Durán P, Mikaeloff F, Struyf N, Österroos A, Lehmann S, Kallioniemi O, Saarela J, Tyner JW, Erkers T, Enserink JM, Aittokallio T. PMID: 42135420 [PubMed - as supplied by publisher]
	Development and validation of a novel prognostic index for mantle cell lymphoma integrating TP53 mutations (MIPI53). Br J Haematol Bastos-Boente M, Medina-Herrera A, Navarro-Bailón A, Ferrero S, Sarasquete ME, Jiménez C, García-Álvarez M, Antón A, Balanzategui A, Moia R, Re A, Boccomini C, Balzarotti M, Zilioli VR, da Silva MG, Díaz-Gálvez FJ, González-Mena B, Peñarrubia MJ, Fernández-Ferrero S, de Ramón C, Blanco Ó, Cabero A, Ladetto M, García-Sanz R, Gutiérrez NC, Martín García-Sancho A, Alcoceba M. PMID: 42134850 [PubMed - as supplied by publisher]
	Survival After Diagnosis of Cardiovascular Disease in Survivors of Adolescent and Young Adult Lymphoma. Eur J Haematol Gowda K, Gupta M, Aguilar A, Cruz C, Warner A, Rodriguez ER, Ahmed S, Cuglievan B, Milam J, Freyer DR, Miller KA, Aune G, Eshelman-Kent D, Albritton K, Koutroumpakis E, Roth ME, Wang J, Hildebrandt MAT. PMID: 42134679 [PubMed - as supplied by publisher]
	Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18-65 years with mantle cell lymphoma (TRIANGLE): 4Â·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network. Lancet Dreyling M, Doorduijn J, Giné E, Jerkeman M, Walewski J, Hutchings M, Mey U, Riise J, Trneny M, Vergote VKJ, Shpilberg O, da Silva MG, Leppä S, Jiang L, Stilgenbauer S, Kerkhoff A, Jachimowicz RD, Heß G, Meerten TV, Wirths S, Herhaus P, Novak U, Dierlamm J, Hänel M, Hanoun C, Sonnevi K, Visco C, Donnarumma D, Ferreri AJM, Patti C, Stefani PM, Pott C, Klapper W, Schmidt C, Unterhalt M, Tix T, Ladetto M, Hoster E, European Mantle Cell Lymphoma Network. PMID: 42134356 [PubMed - indexed for MEDLINE]
	Real-world outcomes of Axicabtagene Ciloleucel CAR-T therapy in large B-cell lymphoma: a single-center observational study. Cytotherapy Alsuhaibani K, Hejab A, Aljasser M, Elhassan T, Ahmed SO, Rasheed W, Alfayez M, Alamer A, Alhayli S, Alshaibani A, Alahmari A, Haroon A, Hanbali A, Chaudhri NA, Saad A, Alotaibi S, Alkhaldi H, Alnughmush A, Alyamany R, Shaheen M, Alfraih FA, Alotaibi AS, Albanyan O, Samarkandi H, Syed F, Alsharif F, Almohareb F, Alzahrani H, Aljurf M, El Fakih R, Albabtain A. PMID: 42134094 [PubMed - as supplied by publisher]
	A Comprehensive Review of the Role of Zanubrutinib for Patients with Chronic Lymphocytic Leukemia. Oncol Ther Ghia P, Brown JR, Shadman M, Wendtner CM. PMID: 42133238 [PubMed - as supplied by publisher]
	Overexpression of TREM1 predicts poor prognosis and chemotherapy resistance in Egyptian acute myeloid leukemia associated with FLT3 internal tandem duplication and CD123 expression and stemness signatures. Discov Oncol Mansor SG, Elgamal R, Saleh MFM, Othman AAA, Nawar SM. PMID: 42133230 [PubMed - as supplied by publisher]
	Immunophenotypic aberrancies in molecularly confirmed acute promyelocytic leukemia: lessons from two cases. J Hematop Prattipati LA, Kar R, Gupta AK, Ronanki K, Thangavel PV. PMID: 42133174 [PubMed - indexed for MEDLINE]
	Re-evaluating the rationale for targeting oxidative phosphorylation in acute myeloid leukemia. Biochem J Chrest BR, Fisher-Wellman KH. PMID: 42132094 [PubMed - indexed for MEDLINE]
	Long-term safety and efficacy of ponatinib in intolerant chronic myeloid leukemia: subanalysis of the observational study of IclusigÂ® (ponatinib) treatment in patients with chronic myeloid leukemia in Italy. Haematologica Breccia M, Iurlo A, Pane F, Scortechini AR, Rossi AR, Santoro M, Cerrano M, Lunghi F, Maggi A, Di Renzo N, Sargentini V, Piciocchi A, Tringali C, Malato A. PMID: 42131958 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 167746

Seite 1 von 8388

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung